HCV - Hepatocellular Carcinoma
Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 7/04/08Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C - 6/24/08 Incidence of and Risk Factors for Hepatocellular Carcinoma in Hepatitis C Patients with Advanced Liver Disease: HALT-C Trial - 5/16/08 Sorafenib (Nexavar) Improves Outcomes in Patients with Hepatocellular Carcinoma - 5/16/08 Combination Therapy Improves Survival Time for Patients with Advanced Liver Cancer - 4/11/08 Human Genetic Variation May Protect Against HCV-related Liver Disease Progression - 1/04/08 Diabetes Is a Risk Factor for Liver Cancer Recurrence after Surgery in Patients with Viral Hepatitis - 7/13/07 New Drug for Treatment of Liver Cancer - 6/12/07
Colchicine Delays the Development of Hepatocellular Carcinoma in Patients with Chronic Viral Hepatitis 10/13/06 Mutation Patterns and Genotypes Associated with Hepatocellular Carcinoma in HBV/HCV Coinfected Patients - 9/01/06 Long-term Effect of Interferon/Ribavirin on Incidence of Hepatocellular Carcinoma - 8/15/06
FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin Treatment Guidelines
HCV Articles by Topic
HCV Liver Issues Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis